Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

April 2, 2025
Uganda launches Africa’s largest malaria vaccine rollout to date
March 25, 2025
Fewer shots, more protection: The promise of combination vaccines
March 20, 2025
How local heroes are reshaping disability care in Mozambique

Stay informed

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
May 5, 2025
Ensuring oxygen access is essential to achieving health for all
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. How Promote Giving, a new investment model, will raise millions for charities
    Inspired by Ares Management's Pathfinder initiative, Promote Giving signatories have committed to donating the equivalent of at least 5% of their selected funds’ performance fees to charities.
    Published: October 2025
  2. Kenya, PATH reaffirm commitment to sustainable health solutions
    Kenya has reaffirmed its commitment to advancing Universal Health Coverage (UHC) through stronger collaboration with PATH focused on sustainable health solutions anchored in local innovation and manufacturing capacity.
    Published: September 2025
  3. The looming antibiotic emergency and why the time for global action is now
    PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  4. PATH part of $12.7M GHIT Fund initiative for malaria, NTDs research.
    PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

968 Item s
968 Item s
    Date
    From
    To
  1. Dramatic reductions in malaria cases and deaths continue over five years with seasonal malaria vaccine-drug combination
    Final results of landmark study confirm two-thirds reduction in cases of malaria, including cases of severe malaria, and deaths from malaria, for RTS,S-drug combination over either intervention given alone in settings of highly seasonal malaria transmission. Results also showed the RTS,S vaccine has similar high efficacy to drugs in preventing malaria in highly seasonal transmission settings, and that overall reduction in malaria incidence likely “tops” 90% among children protected by bednets, vaccines, and drugs.
    Published: August 2023
    Press Release
  2. Join PATH at IAS 2023
    Advancing an integrated HIV and primary health care platform through people-centered service integration, human-centered design, and digital tools
    Published: July 2023
    Press Release
  3. Five lessons from the International Maternal Newborn Health Conference 2023
    Published: July 2023
    Announcement
  4. PATH concerned about proposed cuts in the State, Foreign Operations, and Related Programs Appropriations bill for fiscal year 2024
    Significant proposed cuts to global health security and maternal and child health programs threaten decades of improved health outcomes for millions around the world.
    Published: July 2023
    Statement
  5. Multivalent meningococcal meningitis vaccine from Serum Institute of India achieves WHO prequalification
    This milestone marks a key step forward in protecting African meningitis belt countries from deadly and debilitating meningitis epidemics
    Published: July 2023
    Press Release
Previous
Next